Genome BC Funds $9.8M Project to Sequence 1K Childhood Brain Tumors | GenomeWeb

The Hospital for Sick Children and the Michael Smith Genome Sciences Center are conducting a whole-genome sequencing study of 1,000 pediatric brain cancer tumors.

The aim of the study is to find markers that stratify patients for treatment in clinical trials, to identify risk factors that may predispose children to this type of cancer, and to find markers associated with disease prognosis.

The project is being funded with C$9.8 million by Genome BC and other partners and is part of Genome Canada's Large-Scale Applied Research Project Competition.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.